Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) (CLGN)

CUSIP: 19516R107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio)
Shares outstanding
12,690,589
Total 13F shares
1,813,871
Share change
+863,514
Total reported value
$24,376,000
Price per share
$13.44
Number of holders
15
Value change
+$11,638,720
Number of buys
14
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 19516R107?
CUSIP 19516R107 identifies CLGN - Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) (CLGN) as of Q1 2021

As of 31 Mar 2021, Collplant Biotechnologies Ltd. - Ordinary Shares, par value NIS 1.50 per share (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) (CLGN) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,813,871 shares. The largest 10 holders included MEITAV DASH INVESTMENTS LTD, INVESTMENT MANAGEMENT OF VIRGINIA LLC, FRIESS ASSOCIATES LLC, VILLERE ST DENIS J & CO LLC, BENJAMIN F. EDWARDS & COMPANY, INC., BROWN ADVISORY INC, Weil Company, Inc., RAYMOND JAMES & ASSOCIATES, Sigma Planning Corp, and SABBY MANAGEMENT, LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.